News Press Releases Vima Therapeutics Launches to Advance the First Oral Therapy for People with Dystonia and Related Movement DisordersMay 29, 2025 Media Movement disorder biotech Vima steps onto scene with $60MEndpoints NewsMay 29, 2025
